The ₹572-crore IPO of MobiKwik was subscribed over 26 times in retail category, followed by 7.5 times in NII segment.

Vishal Mega Mart's IPO presents an opportunity to invest in a familiar retail brand. However, geographic concentration and a nascent e-commerce business might limit its growth potential.

Shares of Sai Life Sciences were trading at a premium of ₹28 in the grey market, at 4:30 PM on December 11, as per reports. The latest GMP for Sai Life Sciences IPO indicates an expected listing price of ₹577 per share with a potential listing gain of 5%.

The IPO of Vishal Mega Mart aims to raise Rs 8,000 crore via an offer for sale of 102.56 crore shares, while that of Mobikwik is looking to raise Rs 572 crore through an entirely fresh issue of 2.05 crore shares.

Get the latest updates on the company's financial performance, strategic acquisitions, and market shifts. Explore detailed insights on mergers, acquisitions, financial results, and leadership changes that are shaping the business landscape across industries.

Three mainboard IPOs- One Mobikwik Systems, Vishal Mega Mart and Sai Life Sciences, open for bidding today, on Wednesday, December 11.

The initial public offering (IPO) of supermarket chain Vishal Mega Mart opened for public subscription on Wednesday, with an overall subscription of 0.14 times by 11:36 AM on the first day. The IPO will close on December 13.

The IPO which was slated to open for subscription today (December 11), is a complete offer for sale (OFS) comprising 1,025,641,025 shares

Those who were allotted shares in the anchor round included SBI Mutual Fund, Government of Singapore, Nomura Funds Ireland Public Ltd, Axis Mutual Fund (MF), HDFC MF and ICICI Prudential MF, according to a circular uploaded on BSE's website.